RNAC
Cartesian Therapeutics Inc.
$7.24
+$0.09(+1.26%)
42
Overall
40
Value
45
Tech
--
Quality
Market Cap
$198.15M
Volume
127.39K
52W Range
$5.98 - $26.50
Target Price
$36.43
Company Overview
| Mkt Cap | $198.15M | Price | $7.24 |
| Volume | 127.39K | Change | +1.26% |
| P/E Ratio | -2.6 | Open | $7.16 |
| Revenue | $38.3M | Prev Close | $7.15 |
| Net Income | $-77.4M | 52W Range | $5.98 - $26.50 |
| Div Yield | N/A | Target | $36.43 |
| Overall | 42 | Value | 40 |
| Quality | -- | Technical | 45 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC) and Galmed Pharmaceuticals (GLMD)
Brian Anderson•4 days ago
Wedbush Remains a Buy on Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•9 days ago
Cantor Fitzgerald Sticks to Its Hold Rating for Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•9 days ago
Mizuho Securities Reaffirms Their Buy Rating on Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•16 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $7.24 | +1.3% | 127.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW